Navigate MDR and IVDR Transition with Confidence, Control, and Compliance
The EU MDR / IVDR Transition Playbook provides a comprehensive framework for planning, governing, and executing successful regulatory transitions under the European Union Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Covering transition strategy, gap assessments, classification, technical documentation, clinical and performance evidence, post-market surveillance, notified body engagement, and implementation planning, this playbook helps manufacturers build a structured path to certification while reducing compliance risks. Designed for regulatory, quality, clinical, and executive teams, it offers practical guidance, decision frameworks, readiness checklists, and governance tools to support efficient and sustainable MDR and IVDR compliance.
Table of Contents
Chapter 1. Transition Strategy, Scope, and Governance
1.1 What MDR and IVDR Transition Must Achieve
1.2 Portfolio Scope, Legacy Certificates, and Market Exposure
1.3 Transition Pathways, Deadlines, and Decision Gates
1.4 Program Governance, Roles, and Workstream Cadence
1.5 Executive Dashboard and Transition Risk Register
Chapter 2. Gap Assessment and Remediation Roadmap
2.1 Current-State Diagnostic Across Product, QMS, and Markets
2.2 MDR and IVDR Gap Assessment Methodology
2.3 Product Prioritization, Rationalization, and SKU Decisions
2.4 Remediation Roadmap, Critical Path, and Resource Plan
2.5 Stage-Gate Reviews and Management Oversight
Chapter 3. Classification, Conformity Assessment, and QMS Readiness
3.1 MDR and IVDR Classification Rules and Borderline Issues
3.2 Conformity Assessment Routes and Certificate Strategy
3.3 QMS Upgrades for MDR and IVDR Compliance
3.4 Economic Operators, PRRC, and Distributor Controls
3.5 Internal Audit, Management Review, and Inspection Readiness
Chapter 4. Technical Documentation and Product Evidence Package
4.1 Technical File Architecture and Documentation Standards
4.2 General Safety and Performance Requirements Mapping
4.3 Risk Management, Benefit-Risk, and Usability Evidence
4.4 Labeling, IFU, UDI, and Claims Control
4.5 Technical Documentation Readiness Checklist
Chapter 5. Clinical Evaluation and IVDR Performance Evaluation
5.1 Clinical Evaluation Strategy for Medical Devices
5.2 Clinical Evidence Gaps, Equivalence, and Literature Review
5.3 IVDR Performance Evaluation Strategy and Evidence Model
5.4 Scientific Validity, Analytical Performance, and Clinical Performance
5.5 CER, PER, SSCP, and SSP Documentation Standards
Chapter 6. PMS, PMCF, PMPF, Vigilance, and Lifecycle Control
6.1 PMS System Design and Data Source Mapping
6.2 PMCF and PMPF Planning, Execution, and Reporting
6.3 PSUR, PMS Report, Trend Reporting, and Vigilance
6.4 Change Control, Significant Change, and Legacy Device Monitoring
6.5 Lifecycle Governance After MDR and IVDR Certification
Chapter 7. Notified Body Engagement and Submission Management
7.1 Notified Body Selection, Capacity, and Contracting Strategy
7.2 Submission Planning, Sequencing, and Dossier Packaging
7.3 Notified Body Question Management and Response Governance
7.4 Audit Preparation, Findings, CAPA, and Certification Closure
s7.5 EUDAMED, Registration, and Post-Certification Obligations
Chapter 8. Implementation Roadmap and External Support Options
8.1 Building the MDR / IVDR Transition Implementation Plan
8.2 Internal Capabilities, Resourcing, and Change Management
8.3 Support From Large Consulting Firms
8.4 Specialist Regulatory, Clinical, Quality, and Notified Body Advisors
8.5 Independent Management Consultants Through Umbrex